has brought on two biopharma executives to take charge of its clinical operations and drug development work. Incyte’s Hiroomi Tada joined as chief medical officer, while Aquinox’s Lloyd Mackenzie will serve as chief development officer. Tada was most recently vice president of targeted therapies and translational sciences at Incyte, where he helped guide the company’s […]
PRESS RELEASE
Notable Labs Presents Clinical Platform Validation Data at the 2023 AACR Conference
100% accuracy predicting clinical responders with Notable’s PPMP with enhanced machine learning…